FSH Profiles Research Articles

Participation of the insulin-like growth factor system in the early maturity in juvenile male European sea bass

It is known that the insulin-like growth factor (Igf) system is involved in gonadal development and, in turn, reproduction in vertebrates. In this study, the circulating levels of Igf-1 and follicle-stimulating hormone (Fsh) were assessed as physiological signals related to gonadal maturation stage in juvenile male European sea bass at 1 year of age. The seasonal profiles of Igf-1 and Fsh were analyzed in non-precocious (NP) and precocious (PR) fish during the early onset of puberty. Subsequently, gonadal expression patterns of the three igf genes and their two receptors, igf-1r and igf-2r, were studied during their first year of life. The analysis was continued to evaluate the mRNA expression profiles of three genes (sox17, scf, nf2) mediating spermatogenesis progression. Collectively, these results demonstrated that PR males have higher circulating levels of Igf-1 as compared to NP fish before and during the putative gonadal development period (PGD). Plasma Fsh levels were significantly higher in PR males as compared to NP fish before the start of the PGD period, although this was followed by a decrease in Fsh levels and a subsequent recovery, coinciding with the reproductive season (February). Results showed that the total variance associated with the appearance of precocity may be explained by the contribution of factors such as body size and plasma levels of Igf-1, Fsh and sex steroids in male sea bass. Expression of igfs was high during stage I, and this was significantly correlated with the expression of genes related to cell cycle progression, including sox17, scf and nf2. Finally, the decreased expression of all these gonadal factors in precocious animals suggests their potential involvement in regulating the proliferative growth of spermatogonia and supporting cells during the early stages of spermatogenesis, thus evoking the onset of puberty in male sea bass.

The Influence of Obesity and IL-6 on Infertile Iraqi Women with COVID-19 Complications

Infertility is one of the types of diseases that occur in the reproductive system. Obesity is a state that can be occurred due to excessive fats, the progression in obesity stage results in a change in adipose tissue and the development of chronic inflammation, endocrine glands disorders and women’s reproductive system, and also increase the infection with covid-19. The study aimed to investigate the effect of the obesity, lipid-profile, and IL-6 on hormones-dysregulation in infertile-women with COVID-19 complications. The current study included 70 samples: 50 infertility-women-with-covid-19-infected, 20 healthy-women/control, the ages of both patients and healthy subjects were selected within the range 18-34 years. Levels of FBS, LH, FSH, and testosterone and lipid profile were measured in addition to calculating BMI. The result showed a significant increase in lipid profile but no HDL that revealed a considerable decline in its level (P=0.001) in patients group relative to control group. Also, the results showed highly increase in LH and LH/FSH-ratio (p≤0.05(but no FSH that revealed a considerable decline in its level (p≤0.05). The results also showed that the values of IL-6 (7.46±1.90 ng/ml) and BMI (30.10 ±6.17 kg/m2) in the patients group were significantly higher (P-value=0.001) than their values in the control group (3.13±0.79), (22.09±2.63 kg/m2), respectively. Conclusion: Obesity and Corona-virus-infection negatively affect ovulation in infertile-women due to their effect on the pituitary-gland-hormones, in addition to causing chronic-infections that lead to an increase in the level of interleukin-6, which increases of pituitary gland disorder and the difficulty of treating infertility and increasing of corona complications.

Preovulatory LH and FSH profiles of aluteal cycles

Interovulatory intervals are significantly shortened in aluteal cycles (Coffman et al, Theriogenology. 2014;82:1241-45). We hypothesized that the early return to estrus and ovulation would result from a marked elevation in gonadotropins. Therefore, the aim of this study was to characterize the LH and FSH blood profiles and follicle development of cycling mares during the preovulatory period of aluteal cycles. Eight cycling mares were studied during one control (luteal) cycle (CTRL) and one aluteal cycle (AL), arranged in a crossover design. With the aid of serial ultrasound exams, mares detected in estrus and with ≥ 35 mm follicles were treated with deslorelin acetate (1.8 mg intramuscularly). At detected ovulation (Day 0), mares were randomly allotted to a CTRL or an AL cycle as previously described: administration of 500 mcg of cloprostenol twice daily on Days 0, 1, and 2 and once daily on Days 3 and 4. Blood samples for RIA determination of plasma LH and FSH concentrations were collected daily. Areas under the curve (AUC) for concentrations of plasma LH and FSH from samples collected starting six days preceding ovulation (Day 0) were calculated with the linear interpolation trapezoidal method and compared between groups using a t-test. Interovulatory intervals (IOI) were compared using a paired t-test and a Sign test was used to compare the number of dominant follicles (≥ 28 mm), ovulations and ovulationfailures. The significance level was set as p ≤ 0.05 and a trend as 0.05 < p ≤ 0.1. Total AUC concentrations (± SEM) of LH for AL and CTRL groups were 41.57 ± 8.72 ng·day·mL-1 and 16.69 ± 4.17 ng·day·mL-1, respectively (p = 0.012) and FSH for AL and CTRL groups were 68.35 ± 11.44 ng·day·mL-1 and 45.60 ± 5.69 ng·day·mL-1, respectively (p = 0.079). Mean (± SD) IOI of AL cycles was significantly shorter than that of CTRL cycles (12.88 ± 1.35 days vs. 21.38 ± 1.30 days, p < 0.0001). A significant number of mares (5/8, 62.5%) presented an increase in the number (median ± IQR) of dominant follicles during AL cycles (2.5 ± 1.75 vs. 1.5 ± 1; p = 0.025). In contrast, no significant difference in the median (± IQR) number of ovulations was observed between AL and CTRL groups (1 ± 0 vs. 1 ± 0.75, respectively; p = 0.563). While all AL and CTRL cycles were ovulatory, there was a trend for AL mares to have remaining presumptive preovulatory follicles failing to ovulate (3/8 versus 0/8, respectively; p = 0.083). In conclusion, aluteal cycles were characterized by elevated concentrations of blood LH and FSH during the preovulatory period. These elevated gonadotropins were likely associated with the increase in the number of dominant follicles that became presumptive preovulatory follicles in aluteal cycles.

IN-DEPTH GLYCOSYLATION PROFILING OF R-HFSH-ALFA AND R-HFSH-DELTA IN COMPARISON WITH HUMAN PITUITARY FOLLICLE STIMULATING HORMONE (HFSH)

The glycosylation profile of recombinant human FSH (r-hFSH) is an important attribute of this molecule, defining its net biological effect, safety and efficacy. The most recently developed r-hFSH (r-hFSH-delta) is produced in a human cell line and has a distinct pharmacokinetic/pharamcodynamic (PK/PD) profile versus r-hFSH-alfa, which is produced in a hamster cell line: r-hFSH-delta had a higher elimination half-life and produced a higher ovarian response and higher serum concentrations of inhibin B and estradiol. This PK/PD profile was attributed to the higher proportion of tri- and tetra-sialylated glycans and the presence of both α2,3- and α2,6-linked sialic acid in r-hFSH-delta. The aim of the current study was to compare the glycosylation profiles of r-hFSH-alfa (Gonal-f, Merck KGaA) and r-hFSH-delta (Rekovelle, Ferring Pharmaceuticals) with endogenous pituitary-derived human FSH (p-hFSH).

Very cool white LED light improves reproductive performance and up-regulates expression of reproductive genes in layers

This study was carried out to evaluate the effect of light color temperature on reproductive performance and the expression pattern of GnRH-1 and FSH β genes in layers. At lay, 165 Fayoumi healthy pullets were separated into well ventilated, environmentally controlled rooms. Birds were allocated into three groups with 55 birds each (5 males and 50 females) till 3 months after laying, representing base generation (F0). Fertile eggs were collected and incubated, and the newly hatched chicks were also divided into three groups from the first day of life till 3 months after laying, representing the first generation (F1). In the two generations, the first group was exposed to cool white LED light (day light) (6500 kelvin); the second group was exposed to very cool white LED light (sky blue light) (10000 kelvin); and the third group was exposed to warm white LED light (yellow light) (2700 kelvin). The expression profiles of GnRH-1 and FSH β genes and the serum level of FSH were evaluated in birds of the two generations. Blue light-exposed groups exhibited better reproductive performance, higher up-regulation of GnRH-1 and FSH β genes and increased FSH levels than those exposed to either the white or yellow light colors. A comparison between F0 and F1 revealed an improved profile for F1 birds. It therefore appears that blue LED light could improve the reproductive status of laying chickens.

Hormonal rehabilitation of patients with cervical cancer after radical surgical treatment

Radical surgical treatment with and without radiation often induces symptoms of premature menopause in cervical cancer (CC) patients. Few retrospective studies seem to suggest that hormonal replacement therapy (HRT) is not detrimental for patients with CC and can improve life quality in this group of women. To investigate the effect of HRT on menopausal symptoms inpatients with С C history, 85 patients after CC treatment, 22-51 years old, were included into this research. In 59 patients HRT was carried out to overcomepostovariectomic syndrome (POES). Severity of menopausal symptoms, serum estradiol, FSH and lipid profiles were evaluated. The research showed high therapeutic effect as to reducing the frequency of postovariectomic frustration in HRT application. No recurrences of CC were observed in this group of patients. HRT side effects were extremely rare. HRT can effectively cure climacteric symptoms in women with surgical menopause induced by CC treatment.

P–705 Basal FSH and AMH profiles impact embryo morphokinetics in a maternal age-dependent manner

Abstract Study question Do maternal AMH and basal FSH profiles impact embryo morphokinetics and does this relationship change with maternal age? Summary answer Embryo morphokinetics varies with basal FSH and AMH levels and this relationship changes in advanced maternal age (AMA). What is known already Basal FSH and AMH levels have been utilised as markers of ovarian reserve/response and IVF/ICSI outcomes. Basal FSH better reflects post-IVF/ICSI live birth occurrence in pre-AMA patients, while AMH appears more robust in AMA patients. Whilst plasma AMH levels reflect oocyte yield, recent data suggest that plasma basal FSH and intrafollicular AMH levels specifically reflect oocyte quality. Oocyte and embryo developmental competence is associated with faster fertilisation and embryonic morphokinetics. The assessment of the relationship between developmental morphokinetics and maternal basal FSH and AMH plasma profiles shall contribute for a better understanding of their roles as fertility markers and regulators. Study design, size, duration Retrospective cohort study including 1961 first autologous ICSI cycles performed from 2014 to 2020, providing 10774 embryos grouped according to maternal AMH and basal FSH levels in: CF [concordant favourable; AMH&amp;gt;1 (ng/mL), FSH≤10 (IU/L); n = 8055)]; DFA (discordant with favourable AMH; AMH&amp;gt;1, FSH&amp;gt;10; n = 768); DFF (discordant with favourable FSH; AMH≤1, FSH≤10; n = 1362) and CU (concordant unfavourable; AMH≤1, FSH&amp;gt;10; n = 589). Morphokinetic parameters were compared among groups in total, ≤35 (pre-AMA) and &amp;gt;35 (AMA) years old patients, separately. Participants/materials, setting, methods Patients aged 20 to 45 with FSH and AMH levels measured on menstrual cycle day 2 underwent ovarian stimulation, ovum pick-up and ICSI. Embryos were cultured in a time-lapse incubator (Embryoscope). Fertilisation and cleavage morphokinetic parameters [tPNa (time of pronuclei appearance, tPNf (time of pronuclei fading), t2, t3, t4, t5 and t8] were annotated and compared among AMH/FSH groups with the Kruskal-Wallis nonparametric test, followed by a post hoc multiple comparison with Bonferroni correction. Main results and the role of chance In overall embryos, tPNa, tPNf, t2 and t3 varied between AMH/FSH groups. CF were faster than CU embryos for all these parameters [(mean±SEM; hours); tPNa: 6.8±0.02 vs. 7.1±0.08; tPNf: 24.13±0.04 vs. 24.49±0.14; t2: 27.05±0.05 vs. 27.36±0.16; t3: 36.94±0.07 vs. 37.54±0.22 (p &amp;lt; 0.001)]. In addition, CF were faster than DFA (p &amp;lt; 0.001), but not than DFF embryos, for tPNf (CF: 24.13±0.04; DFF: 24.23±0.14; DFA: 24.57±0.14) and t2 (CF: 27.05±0.05; DFF: 27.22±0.12, DFA: 27.42±0.15). In AMA patients, faster morphokinetics was observed when one or both hormonal values were favourable; tPNf, t2 and t3 were reached earlier in CF compared to CU (tPNf: 24.17±0.05 vs. 24.52±0.15; t2: 27.13±0.06 vs. 27.43±0.17; t3: 37.09±0.08 vs. 37.63±0.24; p &amp;lt; 0.05), but not to DFF (tPNf: 24.22±0.12; t2: 27.27±0.14, t3: 36.92±0.19) or DFA embryos (tPNf: 24.39±0.14; t2: 27.34±0.17, t3: 37.26±0.23). Differently, in pre-AMA patients, faster morphokinetics was associated with favourable basal FSH regardless of AMH levels; tPNa and tPNf were reached earlier in CF compared to DFA and CU (p &amp;lt; 0.005), but not to DFF embryos (tPNA: 6.68±0.03, 6.96±0.13, 7.13±0.14, 7.12±0.19; tPNf: 24.05±0.07, 24.27±0.21, 25.14±0.34, 24.37±0.36; for CF, DFF, DFA and CU, respectively). Limitations, reasons for caution Our study is subjected to the intrinsic limitations of a retrospective analysis and the results could have been affected by variables that were not controlled for. Wider implications of the findings: The findings suggest that lower basal FSH levels are associated with faster early morphokinetics likely reflecting superior oocyte quality in pre-AMA patients. The present data may contribute to improve ART prognostic strategies and provide valuable clues for a better understanding of hormonal regulation of oocyte developmental competence. Trial registration number Not applicable

P–587 Highly purified human menopausal gonadotrophin (HP-hMG, Menopur) as a ready-to-use solution for injection in pre-filled pen is bioequivalent to HP-hMG powder for reconstitution

Abstract Study question Are serum FSH levels after single subcutaneous dosing of HP-hMG in a liquid formulation and a powder formulation bioequivalent? Summary answer The 90% CIs for the geometric mean ratios of serum FSH AUCt and Cmax were both within 0.8000–1.2500, thus the two formulations are bioequivalent. What is known already For several decades, HP-hMG (Menopur) has been used for the treatment of infertility; its efficacy and safety compared to other gonadotropins have been consistently demonstrated in several prospective, randomised controlled trials and meta-analyses (Deeks et al 2018; Bordewijk et al 2019). Menopur powder for reconstitution is available in multidose and single dose formulations. Up to 3 single dose vials (each containing 75 IU) may be dissolved into 1 mL solvent for administration. Recently, and for the first time, Menopur has been successfully formulated in a stable, ready-to-use solution for injection, which may be administered by a pre-filled pen. Study design, size, duration This was a randomised, two-way crossover, single dose, bioequivalence trial comparing Menopur liquid injected by pre-filled pen, with Menopur powder injected by conventional syringe and needle. The primary endpoints were AUCt and Cmax of baseline-adjusted FSH. Pituitary-suppressed, healthy women were randomised to receive one treatment sequence including a single subcutaneous injection of 450 IU Menopur liquid (600 IU/0.96 mL) and of 450 IU Menopur powder by two subcutaneous injections of 225 IU in 1 mL. Participants/materials, setting, methods Blood samples were collected pre- and post-dose, until 9 days after each injection. The PK parameters of FSH and hCG were assessed by noncompartmental methods with adjustment for endogenous pre-dose levels. Highly sensitive and specific electrochemiluminescence immunoassays were used for quantification and the LLOQ of the FSH and hCG assays were 1.47 mIU/mL and 0.5 mIU/mL, respectively, and the total validated CV was within 5% for both assays. Main results and the role of chance In total, 76 women were randomised and 56 completed the trial. The main reason for discontinuation was insufficient pituitary suppression prior to the second administration of HP-hMG. The mean FSH and hCG serum concentration-time profiles were comparable between the two HP-hMG formulations. The geometric mean ratios and 90% confidence intervals of FSH for HP-hMG liquid versus HP-hMG powder were 1.12 [1.0562; 1.1889] for AUCt and 1.17 [1.0946; 1.2490] for Cmax, showing that the two formulations were bioequivalent. Maximal serum FSH concentrations were reached at 18.19 h for HP-HMG liquid and 15.55 h for HP-hMG powder. In addition to FSH, the PK parameters for hCG were compared between the two HP-hMG formulations. The geometric mean ratios and 90% confidence intervals for HP-hMG liquid versus HP-hMG powder were 0.93 [0.86; 1.01] for AUCt and 0.94 [0.86; 1.02] for Cmax. There was no difference between the two groups in the incidence or severity of adverse events, and both preparations were well tolerated. Mild injection site reactions were less common after administration of HP-hMG liquid by a single injection compared to HP-hMG powder by two injections and were mostly related to pain and erythema after drug administration. Limitations, reasons for caution This bioequivalence study is based on the comparison of single dose administrations in healthy female volunteers of reproductive age. Wider implications of the findings: The new HP-hMG solution for injection in a pre-filled pen will deliver the efficacy and safety of Menopur in a convenient delivery device. Trial registration number NA

A Correlation Study between Polycystic Ovarian Syndrome (PCOD) and Its Related Endocrinal Hormones in Udaipur, Rajasthan, India

Background: Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting 5–10 % of women of reproductive age. It generally manifests with oligo/anovulatory cycles, hirsutism and polycystic ovaries, together with a considerable prevalence of insulin resistance. Objectives: The objective of the study is to establish correlation among testosterone, insulin, FSH, LH and lipid profile among the women with polycystic ovary syndrome (PCOS), in order to evaluate their diagnostic and prognostic significance. Methodology: This study includes total 300 female participants of age Group between 18-40 year of age. They were divided in to two groups. Group 1(n=150) includes women having PCOD and Group 2(n=150) is control Group. Fasting Blood samples were obtained from all participants to measure Blood sugar, Lipid Profile insulin, HOMA-IR, Testosteron, FSH, LH and Prolactine. Result: The Mean level of S.Testosteron, S.FSH, S.LH, S.Prolactine and HOMA-IR Fasting Blood sugar, S.cholesterol, S, and Triglyceride S.Insulin is found to be Lower Control Group as compared to PCOD group and difference among them found to be statically significant. Conclusion: From our study I would like to conclude that a PCOS, as a syndrome, has got multiple components including reproductive, metabolic and hormonal, with long-term health concerns that cross the life span. Moreover, PCOS patients have a higher risk of metabolic and cardiovascular diseases and their related morbidity, if compared to the general population.

Status of Estrogen Receptor Beta Gene Polymorphisms rs1256049 and rs4986938 in a cohort of South Indian women with Primary ovarian insufficiency

The current study is aimed to investigate the role of estrogen receptor beta gene polymorphisms for causation of Primary Ovarian insufficiency (POI) in south Indian women. Primary Ovarian insufficiency (POI) is a menstrual disorder presenting with Primary and secondary amenorrhea, decreased estradiol levels and increased gonadotrophin levels. Most cases of POI remain unresolved even after exhaustive investigations and is a significant cause of infertility in women in the reproductive age. In this study a total of 276 subjects, of which 138 POI patients and 138 controls were analysed for biochemical profiles of FSH, LH and Estradiol. Genotypic frequencies were calculated for different models of the SNP rs1256049 and rs4986938 in the Estrogen receptor Beta gene by PCR-RFLP (Restriction length polymorphism) analysis. Statistically, significant relation is found for FSH, LH and Estradiol profiles of a different group of Premature ovarian insufficiency and controls (p&lt;0.0001). Genotypic frequencies between patients and controls were compared, and strength of the interdependence of genotypes and POI is confirmed by the odds ratio and 95% confidence intervals. Incidence of 1082 G&gt;A (rs1256049) polymorphisms and 1730 G&gt;A (rs4986938) were not significantly different in both patient and control group (P=0.21 and P=0.4). The presence of 1082 G&gt;A (rs1256049) polymorphisms and 1730 G&gt;A (rs4986938) is not associated with causation of Premature ovarian insufficiency in south Indian women.

Status of Estrogen Receptor Beta Gene Polymorphisms rs1256049 and rs4986938 in a cohort of South Indian women with Primary ovarian insufficiency

The current study is aimed to investigate the role of estrogen receptor beta gene polymorphisms for causation of Primary Ovarian insufficiency (POI) in south Indian women. Primary Ovarian insufficiency (POI) is a menstrual disorder presenting with Primary and secondary amenorrhea, decreased estradiol levels and increased gonadotrophin levels. Most cases of POI remain unresolved even after exhaustive investigations and is a significant cause of infertility in women in the reproductive age. In this study a total of 276 subjects, of which 138 POI patients and 138 controls were analysed for biochemical profiles of FSH, LH and Estradiol. Genotypic frequencies were calculated for different models of the SNP rs1256049 and rs4986938 in the Estrogen receptor Beta gene by PCR-RFLP (Restriction length polymorphism) analysis. Statistically, significant relation is found for FSH, LH and Estradiol profiles of a different group of Premature ovarian insufficiency and controls (p A (rs1256049) polymorphisms and 1730 G>A (rs4986938) were not significantly different in both patient and control group (P=0.21 and P=0.4). The presence of 1082 G>A (rs1256049) polymorphisms and 1730 G>A (rs4986938) is not associated with causation of Premature ovarian insufficiency in south Indian women.

Ovarian responses and FSH profiles at superovulation with a single epidural administration of gonadotropin in the Thai-Holstein crossbreed.

The conventional method of ovarian superstimulation requires multiple injections of gonadotropins which is time-consuming and may be stressful for the cows. This study was designed to determine whether a single epidural injection of FSH (EI group) would induce the superovulatory response in the Thai-Holstein crossbreed and evaluate FSH plasma hormone concentrations. Eight cows (replication = 3; n=24) were assigned to one of 2 treatments in switch back design. Control group (n=12): cows were received 400 mg FSH twice daily by intramuscularly for 4 days (80, 80, 60, 60, 40, 40, 20 and 20 mg), EI group (n=12): cows were received 400 mg FSH by single epidural injection. Data were collected in term of ovarian follicle responses, superovulatory responses, ova/embryo collection. FSH concentrations were examined using ELISA. The total follicular responses during oestrus were not different between treatments; however, the large follicles were less frequent (P < 0.01) while the medium follicle sizes were higher (P < 0.05) in the EI group. The plasma concentration of FSH in EI was dramatically increased within 2 hours before decreasing sharply thereafter (P < 0.01) and did not remain above baseline after 10 hours of administration. The embryo quality was better in the control than the EI groups (P < 0.05). Interestingly, the number of ovulation cysts in the EI group was 50%. The ovarian responses and embryo quality in the cows with cysts were worse compared with the non-cyst groups (P < 0.05). In conclusion, alternative protocols decreased the superovulatory response and increased poor embryo quality in Thai-Holstein crossbred. Also, the incidence of ovarian follicular cysts is higher in the EI group.

Soil morphostructural characterization and coffee root distribution under agroforestry system with Hevea Brasiliensis

Land use and tillage practices may change soil structure and undermine sustainable agriculture; however, such changes are hardly identified in the short term. In this sense, agroforestry systems have been used to reduce soil degradation and promote sustainable production in coffee plantations. These areas are expected to have well-structured soils and hence improved root distribution. This study aimed to evaluate soil quality by the morphostructural and root distribution analyses comparing open-grown coffee and coffee in agroforestry systems with rubber trees for 19 years, in an Oxisol in northern Paraná State (Brazil). Treatments consisted of open-grown coffee (OG), coffee partially shaded by rubber trees (PSH), and coffee fully shaded by rubber trees (FSH). The mapping of morphostructural features and soil resistance to penetration in “cultural profile” walls identified changes in soil structure resulting from different tillage systems. Root distribution was better in coffee plants grown in PSH and FSH systems. At greater depths, cultural profiles of FSH and PSH showed a larger numbers of roots compared to OG. Among the three systems, PSH provided a better environment for root growth and distribution. This result could be attributed to the high biological activity and interaction between roots and aggregates in that profile. The FSH agroforestry system provided less compact morphological structures and more roots throughout the soil profile. The agroforestry systems presented fewer soil structural changes by tillage operations and lower values of soil penetration resistance. Coffee root distribution was an effective indicator of soil quality and consistent with the morphostructural characterization of cultural profile.

Superstimulation of ovarian follicles in cattle: Gonadotropin treatment protocols and FSH profiles

The objective of ovarian superstimulatory treatments in cattle is to obtain the maximum number of viable embryos by stimulating growth of antral follicles and ovulation of competent oocytes. While factors inherent to the donor animal are critical, an increased knowledge of ovarian physiology, gonadotropin biochemistry and the ability to manipulate ovarian function have provided alternatives for the design of simple and successful protocols for superovulation in cattle. Recent protocols have also been made more user-friendly and allowed for the grouping of donors for successful superovulation. Although the number of reports associating FSH profiles with superovulatory response is limited, studies designed to reduce the number of FSH treatments necessary to induce superstimulation may provide guidance for the development of optimized gonadotropin treatment protocols. Although high peak levels of circulating FSH following a single administration of Folltropin-V have been shown to be associated with a reduced superstimulatory response, the ideal treatment protocol would seem to be to increase circulating FSH levels to values comparable to those required for the induction of follicle wave emergence, and to maintain these levels for at least 72 h (or 36 h for superstimulation prior to ovum pick-up) to allow follicles to reach an ovulatory size and acquire the capacity to ovulate.

Study of The Effect of Bisphenol A and Anise Oil on Some Sexual Hormones in Male Albino Rats and Illustration of The Effects of Aphanizomenon Flos-Aquae on Their Actions

Background: Xenoestrogens are compounds like estrogens in effect but not in structure which are mimicking the action of endogenous estrogen and activate estrogen receptor. Phytoestrogens are naturally occurring non-steroidal plant chemicals that can act like the female hormone estrogen. Aphanizomenon Flos-aquae (AFA) is a blue-green microalgal species which has antioxidant properties. Objective: The aim of the study was to clarify the effects of both Bisphenol A (BPA) and anise oil (phytoestrogen) together on some sexual hormonal pattern in male albino rats and illustration of the adverse effects of AFA on their actions. Materials and methods: Thirty male albino rats were used. They were divided into three groups: Group I: control (untreated group), Group II: rats treated with BPA and Anise oil and Group III: rats treated with BPA and Anise oil in addition to AFA. Blood samples were collected for different biochemical investigations. Results: The biochemical results showed highly significant increase (p<0.01) in the activities of ALT, AST, urea, creatinine, FSH, prolactin and lipid profile (total cholesterol, triglycerides, HDL-C, VLDL, LDL/HDL & TC/HDL). While, there was a highly significant decrease (p < 0.01) in LDL-C, total protein, albumin, Globulin, testosterone and LH. These results returned back to the normal values after receiving the AFA as compared to normal group. Conclusion: It could be concluded that phytoestrogen and xenoestrogen have undesirable effects and it is recommended to minimize the utilization of these compounds to protect people from its hazardous effects.

Study of The Effect of Bisphenol A and Anise Oil on Some Sexual Hormones in Male Albino Rats and Illustration of The Effects of Aphanizomenon Flos-Aquae on Their Actions

Background: Xenoestrogens are compounds like estrogens in effect but not in structure which are mimicking the action of endogenous estrogen and activate estrogen receptor. Phytoestrogens are naturally occurring non-steroidal plant chemicals that can act like the female hormone estrogen. Aphanizomenon Flos-aquae (AFA) is a blue-green microalgal species which has antioxidant properties. Objective: The aim of the study was to clarify the effects of both Bisphenol A (BPA) and anise oil (phytoestrogen) together on some sexual hormonal pattern in male albino rats and illustration of the adverse effects of AFA on their actions. Materials and methods: Thirty male albino rats were used. They were divided into three groups: Group I: control (untreated group), Group II: rats treated with BPA and Anise oil and Group III: rats treated with BPA and Anise oil in addition to AFA. Blood samples were collected for different biochemical investigations. Results: The biochemical results showed highly significant increase (p<0.01) in the activities of ALT, AST, urea, creatinine, FSH, prolactin and lipid profile (total cholesterol, triglycerides, HDL-C, VLDL, LDL/HDL & TC/HDL). While, there was a highly significant decrease (p < 0.01) in LDL-C, total protein, albumin, Globulin, testosterone and LH. These results returned back to the normal values after receiving the AFA as compared to normal group. Conclusion: It could be concluded that phytoestrogen and xenoestrogen have undesirable effects and it is recommended to minimize the utilization of these compounds to protect people from its hazardous effects.

MON-453 Endocrine, Bone, and Metabolic Disorders in Adults after Allogeneic Stem-Cell Transplant

Introduction Allogeneic hematopoietic stem cell transplantations (allo-HSCT) is often indicated in malignant hematologic diseases. Conditioning regimens, used to reduce the tumor burden and to prevent transplant rejection, are based on chemotherapy alone or combined with total body irradiation (TBI). Endocrine complications are frequent transplant-related side effects. They have been well described in children studies but less in adulthood. Objective To assess retrospectively endocrine, bone and metabolic disorders in adult patients, 12 months after allo-HSCT. Patients & Methods Inclusion criteria were : patients treated with allo-HSCT from 2006 to 2016 for a malignant hematologic disease; adult and in complete remission at exploration. Exclusion criteria were : anteriority of brain radiotherapy and prior HSCT. Twelve months after HSCT, each patient underwent fasting measurement of IGF1, TSH, fT4, FSH, LH, sex steroids, glycemia, insulin level, and lipid profile. Unless contraindication, adrenal and growth hormone functions were assessed with insulin hypoglycemia test. A dual X-ray absorptiometry was also performed. Results During the inclusion period, 249 patients received allo-HSCT at our institution. Among them, 148 stayed in complete remission 12 months after HSCT and 63 have been explored in our department. The study sample consisted of the 45 patients meeting the inclusion/exclusion criteria. 40 patients had insulin hypoglycemia test. Hypopituitarism was observed in 20 patients (44%) (14 GH deficiency, 8 central adrenal deficiency, 2 central hypothyroidism and 1 central hypogonadism). No predictive factor was found. One patient had central adrenal deficiency after 12 Gy TBI regimen without any corticotherapy. Hypothyroidism was observed in 6 patients (13,6 %), evenly distributed in subclinical, overt and central hypothyroidism. The risk of developing hypothyroidism was higher in patients aged less than 30 y/o at transplantation (OR = 8,5). All premenopausal women (n = 16) had premature ovarian failure. Half of the 18 men were suspected to have spermatogenesis disorder (elevated FSH). Five men had elevated LH with normal testosterone, and one had central hypogonadism possibly attributed to his obesity. Bone mineral density (BMD) was decreased in 33 patients (77 %). Twelve (28 %) had osteoporosis. Conditioning regimen with busulfan was protective of BMD decrease (OR = 0,66 [0,5-0,85], P = 0,02). Obesity was more frequent (20 %) than our national prevalence (14 %). There were no increase in insulino-resistance and diabetes prevalences. Twenty patients (45 %) had dyslipidemia, 14 of them hypertriglyceridemia. Conclusion Our study shows a high frequency of endocrine, bone and metabolic disorders 12 months after allo-HSCT during adulthood. Hypopituitarism is more frequent that previously described, using the gold standard of the GH and adrenal function exploration.

Impotentia generandi in male dromedary camels: FSH, LH and testosterone profiles and their association with clinical findings and semen analysis data

Impotentia generandi (IG) is a major problem in male dromedary camels. The objective of this research was to characterize the FSH, LH and testosterone profiles and their association with clinical findings and semen characteristics in IG-male dromedaries. Semen was collected by electroejaculation from camels with IG (n = 17) and from a fertile group (FERT, n = 5) and was evaluated for motility, viability, abnormality and concentration. According to their sperm counts, the IG-camels were categorized into three groups: those with normal sperm concentration (IG-NC, n = 8), those with oligospermia (IG-OLIGO, n = 5) and those with azoospermia (IG-AZOO, n = 4). Jugular blood was collected from all camels for analysis of FSH, LH and testosterone (T) concentrations. Results showed that the FSH, LH and T levels were higher in the IG-OLIGO and IG-AZOO groups than in the FERT and IG-NC groups (P < 0.05). The IG-camels with small testes showed lower sperm counts (P < 0.01) and greater FSH and T levels (P < 0.05) than the IG-camels with normal-sized testes. Inverse relationships were observed between the sperm counts and both the FSH and the LH levels (P < 0.05). In conclusion, the IG dromedary camels with oligo- and azoospermia were characterized by high serum levels of FSH, LH and T, indicating a condition of spermatogenic failure. In addition, inverse correlations were observed between these hormones and testicular size and sperm count.

Profil hormon FSH, LH dan estradiol serta kadar glukosa darah sidat, Anguilla bicolor bicolor (Mc Clelland, 1844) yang dirangsang hormon HCG, MT, E2 dan anti dopamin

This study aims to analyze the hormone profile of FSH, LH and E2 to the eel after exogenous hormone stimulation and blood glucose levels. Six formulated treatment applied with combination of dopamine antagonize 10 mg.mL–1 (A), estradiol (E2) 3 mg.mL–1 + A (EA), metyltestosteron (MT) 3 mg.mL–1 + A (MTA), hCG 2 mg.mL–1 + EA (hEA) and hCG 2 mg.mL–1 + MTA (hMTA), with (F) physiologis 0.9% NaCl to control. Six group eel (200±15g) reared in a concrete tank with a capacity of 3,400 liters and filled with sea water of 35 mg L–1 as much as 2000 liters. Eels injected 1 mL.kg–1 hormone by intramusculary, were feed to apparent satiation daily for 10 weeks. The study used Completely Randomized Design with one treatment factor, namely hormonal factor and its combination. Fish blood that ware directly concentration to FSH, LH and E2, the enhanced significantly high in the blood plasma on treatment hMTA and hEA P&lt;0.05. Glucose concentration in the blood palsma is high enough in a row on a formula hMTA 67.33 mg.dL–1 and significantly different to P&lt;0.05. The result indicates that induction of exogenous hormone (hMTA) improve FSH, LH and E2. FSH and LH profiles show permutation patterns during the development of eel gonad, beginning with the increase of FSH in the early phases of gonadal development. LH profile moves in line with the increase in E2 during gonadal maturation process eels (A. bicolor bicolor), with blood glucose levels in the normal range. AbstrakThis study aims to analyze the hormone profile of FSH, LH and E2 to the eel after exogenous hormone stimulation and blood glucose levels. Six formulated treatment applied with combination of dopamine antagonize 10 mg.mL–1 (A), estradiol (E2) 3 mg.mL–1 + A (EA), metyltestosteron (MT) 3 mg.mL–1 + A (MTA), hCG 2 mg.mL–1 + EA (hEA) and hCG 2 mg.mL–1 + MTA (hMTA), with (F) physiologis 0.9% NaCl to control. Six group eel (200±15g) reared in a concrete tank with a capacity of 3,400 liters and filled with sea water of 35 mg L–1 as much as 2000 liters. Eels injected 1 mL.kg–1 hormone by intramusculary, were feed to apparent satiation daily for 10 weeks. The study used Completely Randomized Design with one treatment factor, namely hormonal factor and its combination. Fish blood that ware directly concentration to FSH, LH and E2, the enhanced significantly high in the blood plasma on treatment hMTA and hEA P&lt;0.05. Glucose concentration in the blood palsma is high enough in a row on a formula hMTA 67.33 mg.dL–1 and significantly different to P&lt;0.05. The result indicates that induction of exogenous hormone (hMTA) improve FSH, LH and E2. FSH and LH profiles show permutation patterns during the development of eel gonad, beginning with the increase of FSH in the early phases of gonadal development. LH profile moves in line with the increase in E2 during gonadal maturation process eels (A. bicolor bicolor), with blood glucose levels in the normal range.

Impact of a timed-release FSH treatment from 2 to 6 months of age in bulls I: Endocrine and testicular development of beef bulls

In prepubertal males, FSH facilitates Sertoli cell proliferation and testis maturation. The study aimed to determine the effect of an exogenous FSH treatment on hormone secretion and testis development in Angus bulls. Bulls (n = 22) weaned at 53 ± 3.8 days of age were randomized into two treatment groups based on age and pedigree. Beginning at Day 59, bulls were injected im every 3.5 days with either 30 mg FSH (Folltropin-V; NIH-FSH-P1 units) in a 2% hyaluronan solution (FSH-HA, n = 11) or saline (control, n = 11) until Day 167.5. Blood samples to assess FSH, activin A, and testosterone were collected prior to each treatment. To determine how FSH profiles surrounding treatment were affected, three intensive blood sampling periods, each encompassing two treatment administrations, began at Day 66, 108, and 157, and blood was collected at 0, 6, 12, 18, 24, 36, 60, and 84 h respective to time of treatment. Scrotal circumference (SC) and BW were measured monthly. Bulls were castrated at Day 170 to measure testis size, seminiferous tubule diameter, and the number of Sertoli and germ cells per tubule cross-section. During intensive FSH sampling, FSH-HA bulls experienced an increase (P < 0.05) in FSH over control bulls for at least 18 h post-injection in all instances. In blood collected every 3.5 days, FSH concentrations in FSH-HA bulls were increased (P < 0.05) over initial Day 59 concentration from Day 97.5–167.5. FSH concentrations did not differ between treatments from Day 59–90.5, but were greater (P < 0.05) in FSH-HA from Day 94–167.5. Concentrations of activin A assessed for Day 59, 83.5, 94, 129, and 167.5 were greater (P < 0.05) in FSH-HA than control bulls on Day 83.5 and 94. The treatments did not differ (P > 0.1) in testosterone, BW, SC, testis size, tubule diameter, or number of germ cells per tubule. However, the number of Sertoli cells per tubule was greater in FSH-HA than control bulls (45.2 ± 1.4 vs. 41.6 ± 0.9 cells, P < 0.05). In summary, FSH-HA treatment every 3.5 days from Day 59–167.5 maintained elevated FSH for a minimum of 18 h post-injection, likely attributable to the addition of HA. We propose the exogenous FSH-HA treatment initiates a positive feedback loop that includes an increased density of Sertoli cells per tubule cross-section, which is related to increased activin A concentrations on Day 83.5 and 94. Furthermore, this activin A increase preceded an increase in endogenous FSH from Day 94–167.5 in FSH-HA bulls.